Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Sonny7on Oct 27, 2020 9:43pm

99 Views

Post# 31793532

RE:RE:RE:Mackie (083) & Integral (017) Both Market Makers

It doesn’t take much to trick bio, Red. Rumour has it that he is a washed up broker, of the undesirable kind, and with a sour attitude to boot. I wonder how many lives he’s ruined? Now, apparently he’s reaching out to wally with his victims hat on. Does he wonder why he thinks he’s being picked on? (not directed at you but generically speaking here)

There is a bright side bio. You ve been a big help to me. I’m on some acreage in the Boreal forest and folks have been asking and suggesting that I should name the place....... “Horse Meadows”, “Sonny’s Sanctuary”, “Tranquillo Ranch”. ....Nope. In thinking of you, it’s gonna be “Belly Acres”!!!

Good Luck to you. Step gracefully off of the turnip truck and find your path in life.

We Wait

Bullboard Posts

Transportation technology stock secures second major contract in a week